ArticleDiabetologia2019

Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis.

Ana Luisa Perdigoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.